Bioage Labs Inc/$BIOA
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Bioage Labs Inc
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.
- Ticker
- $BIOA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 61
- Headquarters
- EmeryVille, United States
- Website
- bioagelabs.com
Bioage Labs Inc Metrics
BasicAdvanced
$269M
-
-$2.37
-
-
Price and volume
Market cap
$269M
52-week high
$25.96
52-week low
$4.81
Average daily volume
869K
Financial strength
Current ratio
17.189
Quick ratio
16.619
Long term debt to equity
0.006
Total debt to equity
0.008
Interest coverage (TTM)
-378.19%
Profitability
EBITDA (TTM)
-106.02
Gross margin (TTM)
-747.78%
Net profit margin (TTM)
-912.25%
Operating margin (TTM)
-1,026.28%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-18.47%
Return on equity (TTM)
-28.21%
Valuation
Price to revenue (TTM)
22.585
Price to book
0.72
Price to tangible book (TTM)
0.72
Price to free cash flow (TTM)
-2.655
Free cash flow yield (TTM)
-37.67%
Free cash flow per share (TTM)
-2.211
Growth
Revenue change (TTM)
168.06%
Earnings per share change (TTM)
-16.58%
What the Analysts think about Bioage Labs Inc
Analyst ratings (Buy, Hold, Sell) for Bioage Labs Inc stock.
Analyst projections of the future price of Bioage Labs Inc stock.
Bioage Labs Inc Financial Performance
Revenues and expenses
Bioage Labs Inc Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Bioage Labs Inc
Fund name | Fund size | $BIOA weighting |
|---|---|---|
iShares Nasdaq US Biotechnology£BTEK | $1.1B | 0.02% |
iShares Nasdaq US Biotechnology$BTEC | $1.1B | 0.02% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.01% |
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.01% |
SPDR MSCI All Country World IM€SPYI | $7.7B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.